These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34494240)

  • 1. Clinical outcomes of chronic obstructive pulmonary disease phenotypes. One center prospective study.
    Said A; Esmail M; Abdel Naiem E; Zaki Z; Raouf R
    Adv Respir Med; 2021; 89(4):369-377. PubMed ID: 34494240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical phenotypes of COPD and health-related quality of life: a cross-sectional study.
    Chai CS; Liam CK; Pang YK; Ng DL; Tan SB; Wong TS; Sia JE
    Int J Chron Obstruct Pulmon Dis; 2019; 14():565-573. PubMed ID: 30880946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: "the ESPIRAL-ES study".
    Alcázar-Navarrete B; Trigueros JA; Riesco JA; Campuzano A; Pérez J
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1115-1124. PubMed ID: 29692606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
    Calle Rubio M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review.
    Wu JJ; Xu HR; Zhang YX; Li YX; Yu HY; Jiang LD; Wang CX; Han M
    BMC Pulm Med; 2020 Apr; 20(1):103. PubMed ID: 32326924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical phenotypes and heath-related quality of life of COPD patients in a rural setting in Malaysia - a cross-sectional study.
    Chai CS; Mos SB; Ng DL; Goh GM; Su AT; Ibrahim MAB; Musa ANB; Tan SB; Pang YK; Liam CK
    BMC Pulm Med; 2020 Sep; 20(1):254. PubMed ID: 32993591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical phenotypes of COPD and their impact on quality of life: A cross-sectional study.
    Anandan J; Dwivedi DP; Govindaraj V
    Respir Med; 2023 Dec; 220():107452. PubMed ID: 37944828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
    Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
    Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with the Non-Exacerbator Phenotype of Chronic Obstructive Pulmonary Disease.
    Bouhuis D; Giezeman M; Hasselgren M; Janson C; Kisiel MA; Lisspers K; Montgomery S; Nager A; Sandelowsky H; Ställberg B; Sundh J
    Int J Chron Obstruct Pulmon Dis; 2023; 18():483-492. PubMed ID: 37051115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in cardiovascular risk and health-related quality of life in COPD patients according to clinical phenotype.
    Montiel AM; Ruiz-Esteban P; Del Río AD; Valdivielso P; Chaparro MÁS; Olveira C
    Sci Rep; 2024 Apr; 14(1):9687. PubMed ID: 38678074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Readmission Due to Exacerbation of COPD: Associated Factors.
    Cerezo Lajas A; Gutiérrez González E; Llorente Parrado C; Puente Maestu L; de Miguel-Díez J
    Lung; 2018 Apr; 196(2):185-193. PubMed ID: 29445935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is serum iron responsive protein-2 level associated with pulmonary functions and frequent exacerbator phenotype in COPD?
    Acet Öztürk NA; Görek Dilektaşlı A; Demirdöğen E; Coşkun F; Ursavaş A; Karadağ M; Kunt Uzaslan E
    Tuberk Toraks; 2020 Sep; 68(3):252-259. PubMed ID: 33295723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and characteristics of COPD phenotypes - results from the Polish sub-cohort of the POPE study.
    Kania A; Krenke R; Kuziemski K; Czajkowska-Malinowska M; Celejewska-Wójcik N; Kuźnar-Kamińska B; Farnik M; Bokiej J; Miszczuk M; Damps-Konstańska I; Grabicki M; Trzaska-Sobczak M; Sładek K; Batura-Gabryel H; Barczyk A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1613-1621. PubMed ID: 29844667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD.
    Capozzolo A; Carratù P; Dragonieri S; Falcone VA; Quaranta VN; Liotino V; D'Alba G; Castellana G; Resta O
    Respir Care; 2017 May; 62(5):572-578. PubMed ID: 28270543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype.
    Miłkowska-Dymanowska J; Białas AJ; Szewczyk K; Kurmanowska Z; Górski P; Piotrowski WJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3879-3884. PubMed ID: 30568439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High risk of subclinical atherosclerosis in COPD exacerbator phenotype.
    Domenech A; Muñoz-Montiel A; García-Casares N; Rioja J; Ruiz-Esteban P; Gutierrez-Castaño P; Prunera Pardell MJ; Olveira C; Valdivielso P; Sánchez-Chaparro MÁ
    Respir Med; 2018 Aug; 141():165-171. PubMed ID: 30053963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients.
    Wu YK; Su WL; Yang MC; Chen SY; Wu CW; Lan CC
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2475-2485. PubMed ID: 34511892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality in COPD patients according to clinical phenotypes.
    Golpe R; Suárez-Valor M; Martín-Robles I; Sanjuán-López P; Cano-Jiménez E; Castro-Añón O; Pérez de Llano LA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1433-1439. PubMed ID: 29750029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.